These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29120460)
21. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study. Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583 [TBL] [Abstract][Full Text] [Related]
22. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005 [TBL] [Abstract][Full Text] [Related]
23. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis. Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757 [TBL] [Abstract][Full Text] [Related]
30. Analysis of first-trimester combined test results in preparation for a cell-free fetal DNA era. Kose S; Cımrın D; Yıldırım N; Aksel O; Keskinoglu P; Bora E; Cankaya T; Altunyurt S Int J Gynaecol Obstet; 2016 Nov; 135(2):187-191. PubMed ID: 27569022 [TBL] [Abstract][Full Text] [Related]
31. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM; Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118 [TBL] [Abstract][Full Text] [Related]
32. Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers. Bestwick JP; Huttly WJ; Wald NJ J Med Screen; 2013 Jun; 20(2):57-65. PubMed ID: 23761419 [TBL] [Abstract][Full Text] [Related]
33. First trimester combined screening in patients with systemic lupus erythematosus: impact of pre-analytical variables on risk assessment. de Sousa MJR; Ribeiro R; Syngelaki A; Nicolaides KH Clin Rheumatol; 2019 May; 38(5):1251-1255. PubMed ID: 30919147 [TBL] [Abstract][Full Text] [Related]
34. Prenatal reflex DNA screening for trisomy 21, 18 and 13. Wald NJ Expert Rev Mol Diagn; 2018 May; 18(5):399-401. PubMed ID: 29633889 [No Abstract] [Full Text] [Related]
35. First-trimester risk calculation for trisomy 13, 18, and 21: comparison of the screening efficiency between 2 locally developed programs and commercial software. Sørensen S; Momsen G; Sundberg K; Friis-Hansen L; Jørgensen FS Clin Chem; 2011 Jul; 57(7):1023-31. PubMed ID: 21576269 [TBL] [Abstract][Full Text] [Related]
36. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Spencer K; Nicolaides KH BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267 [TBL] [Abstract][Full Text] [Related]
38. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010 [TBL] [Abstract][Full Text] [Related]
39. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371 [TBL] [Abstract][Full Text] [Related]
40. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]